Regenicin Inc. (OTC: RGIN), a development-stage company focusing on tissue-engineered skin substitutes to restore human skin, has seen a sharp rise in its shares in trading today.
Regenicin Inc. (OTC: RGIN), a development-stage company focusing on tissue-engineered skin substitutes to restore human skin, has seen a sharp rise in its shares in trading today.